VYNE Therapeutics Statistics

Total Valuation

VYNE has a market cap or net worth of $46.53 million. The enterprise value is -$31.79 million.

Market Cap	46.53M
Enterprise Value	-31.79M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

VYNE has 14.75 million shares outstanding. The number of shares has increased by 822.56% in one year.

Current Share Class	14.75M
Shares Outstanding	14.75M
Shares Change (YoY)	+822.56%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	6.49%
Owned by Institutions (%)	36.27%
Float	10.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	192.78
Forward PS	193.10
PB Ratio	0.61
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.81, with a Debt / Equity ratio of 0.00.

Current Ratio	5.81
Quick Ratio	5.54
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -90.47% and return on invested capital (ROIC) is -62.69%.

Return on Equity (ROE)	-90.47%
Return on Assets (ROA)	-49.36%
Return on Capital (ROIC)	-62.69%
Revenue Per Employee	$49,300
Profits Per Employee	-$3.41M
Employee Count	10
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.22% in the last 52 weeks. The beta is 1.35, so VYNE's price volatility has been higher than the market average.

Beta (5Y)	1.35
52-Week Price Change	-3.22%
50-Day Moving Average	2.15
200-Day Moving Average	2.22
Relative Strength Index (RSI)	73.05
Average Volume (20 Days)	132,367

Short Selling Information

The latest short interest is 49,968, so 0.34% of the outstanding shares have been sold short.

Short Interest	49,968
Short Previous Month	58,194
Short % of Shares Out	0.34%
Short % of Float	0.50%
Short Ratio (days to cover)	1.23

Income Statement

In the last 12 months, VYNE had revenue of $493,000 and -$34.15 million in losses. Loss per share was -$0.86.

Revenue	493,000
Gross Profit	493,000
Operating Income	-37.70M
Pretax Income	-29.08M
Net Income	-34.15M
EBITDA	n/a
EBIT	-37.70M
Loss Per Share	-$0.86

Full Income Statement

Balance Sheet

The company has $70.19 million in cash and $123,000 in debt, giving a net cash position of $70.06 million or $4.75 per share.

Cash & Cash Equivalents	70.19M
Total Debt	123,000
Net Cash	70.06M
Net Cash Per Share	$4.75
Equity (Book Value)	63.54M
Book Value Per Share	4.31
Working Capital	60.87M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	-26.75M
FCF Per Share	-$1.81

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-7,646.86%
Pretax Margin	-6,885.40%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-6,582.74%

Dividends & Yields

VYNE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-822.56%
Shareholder Yield	-822.56%
Earnings Yield	-72.24%
FCF Yield	-56.59%

Analyst Forecast

The average price target for VYNE is $5.75, which is 82.25% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.75
Price Target Difference	82.25%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	167.61%
EPS Growth Forecast (5Y)	-44.02%

Stock Forecasts

Stock Splits

The last stock split was on February 13, 2023. It was a reverse split with a ratio of 0.0555556:1.

Last Split Date	Feb 13, 2023
Split Type	Reverse
Split Ratio	0.0555556:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2